Successful Treatment of Refractory Folliculitis Decalvans with Secukinumab

    Fathima Ferial Ismail, Rodney Sinclair
    Studysummary Secukinumab effectively treated a difficult case of folliculitis decalvans.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on minerva-access.unimelb.edu.au →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Folliculitis Decalvans: A Multicenter Review of 82 Patients Journal of The American Academy of Dermatology · 2015
    2. Folliculitis Decalvans: A Multicenter Review of 82 Patients Journal of the European Academy of Dermatology and Venereology · 2015